Analysts expect Pliant Therapeutics, Inc. to report revenue of 0.00 for Q2 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q1 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 545,027.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.73 M | 4.11 M | 1.50 M | 685,834.88 | 3.85 M | |||||||||||
| Low Estimate | 463,105.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.44 M | 3.76 M | 1.36 M | 571,144.32 | 3.47 M | |||||||||||
| Consensus Estimate | 504,066.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.59 M | 3.93 M | 1.43 M | 628,489.60 | 3.66 M |
Analysts expect Pliant Therapeutics, Inc. to report earnings per share of -0.36 for Q3 26, against a range of -0.39 to -0.33. The most recent reported quarter, Q2 26, came in at -0.36 , in line with the -0.36 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.95 | -0.82 | -0.92 | -0.71 | -0.43 | -0.38 | -0.32 | -0.36 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.96 | -0.86 | -0.74 | -0.68 | -0.53 | -0.36 | -0.37 | -0.34 | -0.33 | -0.37 | -0.37 | -0.34 | -0.26 | -0.23 | -0.35 | -0.34 | ||||||||||
| Low Estimate | -1.06 | -0.98 | -0.88 | -0.74 | -0.57 | -0.42 | -0.39 | -0.38 | -0.39 | -0.41 | -0.39 | -0.42 | -0.30 | -0.25 | -0.37 | -0.38 | ||||||||||
| Consensus Estimate | -1.01 | -0.92 | -0.81 | -0.71 | -0.55 | -0.39 | -0.38 | -0.36 | -0.36 | -0.39 | -0.38 | -0.38 | -0.28 | -0.24 | -0.36 | -0.36 |
Pull Wall Street consensus for Pliant Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PLRX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PLRX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PLRX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();